DFP-Lite­ra­­tur­s­tu­­dium: Neu­ro­der­mi­tis bei Jugendlichen

Die Unter­bre­chung des Cir­cu­lus vitio­sus aus Juck­reiz – Krat­zen – Ent­zün­dung muss das Ziel sämt­li­cher the­ra­peu­ti­scher Inter­ven­tio­nen sein. Struk­tu­rierte Pati­en­ten­schu­lungs­pro­gramme bewir­ken nicht nur eine deut­li­che Ver­bes­se­rung der kli­ni­schen, son­dern auch der psy­cho­lo­gi­schen Parameter.

Bea­trix Volc-Platzer*

PDF Down­load

zum Fra­ge­bo­gen

Lite­ra­tur:

  1. Mar­go­lis D et al. Per­sis­tence of mild to mode­rate ato­pic der­ma­ti­tis. JAMA Der­ma­tol 2014; 150(6):593–600
  2. Sil­ver­berg JI & Hani­fin JM. Adult eczema pre­va­lence and asso­cia­tion with asthma and other health and demo­gra­phic fac­tors: A US-popu­la­­tion-based study. J All­ergy Clin Immu­nol 2013; 132:1132–38
  3. Mortz CG et al. Ato­pic der­ma­ti­tis form ado­lescence to adult­hood in the TOACS cohort: pre­va­lence, per­sis­tence and comor­bi­di­ties. All­ergy 2015; 70:836–45
  4. Garm­hau­sen D et al. „Cha­rac­te­ri­sa­tion of dif­fe­rent cour­ses of ato­pic der­ma­ti­tis in ado­lescent and adult pati­ents.“ All­ergy 2013; 68:498–506
  5. Bie­ber T et al.“Clinical phe­no­ty­pes and endo­ty­pes of ato­pic der­ma­ti­tis: Where are we, and where should weg go?“ J All­ergy Clin Immu­nol 2017: 139:S58-64
  6. Mar­tel BC et al. „Dis­tinct mole­cu­lar signa­tures of mild extrinsic and intrinsic ato­pic der­ma­ti­tis.“ Exp Der­ma­tol 2016; 25:453–459
  7. Pater­nos­ter L et al. Multi-ances­­try genome wide asso­cia­tion study of 21,000 cases and 95,000 con­trols iden­ti­fies new risk loci for ato­pic der­ma­ti­tis. Nature Genet 2015; 47:1449–1456
  8. Schee­rer C und Eye­rich K. Patho­ge­nese des ato­pi­schen Ekzems. Haut­arzt 2018; 69:191–196
  9. Buss­mann C, Wei­din­ger S, Novak N. Gene­ti­scher Hin­ter­grund der ato­pi­schen Der­ma­ti­tis. J Dtsch Der­ma­tol Ges 2011; 9:670–679
  10. Irvine AD, Leung DYM. Fil­ag­grin muta­ti­ons asso­cia­ted with skin and all­er­gic dise­a­ses. N Engl J Med 2011; 365:1315–1327
  11. Jar­rett R et al. Fil­ag­grin inhi­bits genera­tion of CD1a neo­li­pid anti­gens by house dust mite-deri­­ved phos­pho­li­pase. Sci Transl Med 8(325):325ra18
  12. Jun­ger­sted JM et al. Stra­tum cor­neum lipids, skin bar­rier func­tion and fil­ag­grin muta­ti­ons in pati­ents with ato­pic eczema. All­ergy 2010; 65(7):911–918
  13. Wei­din­ger S & Novak N. Ato­pic der­ma­ti­tis. Lan­cet 2016; 387:1109–1122
  14. Misery L, Huet F, Gouin O et al. Cur­rent phar­maceu­ti­cal deve­lo­p­ments in ato­pic der­ma­ti­tis. Curr Opin Phar­ma­col 2019; 46:7–13
  15. Rei­ger M, Schwier­zeck V, Traidl-Hof­f­­mann C. Ato­pi­sches Ekzem und Mikro­biom. Haut­arzt 2019; 70:407–415
  16. Dal­gard FJ, Gie­ler U, Tomas-Ara­­go­­nes L et al. The psy­cho­lo­gi­cal bur­den of skin dise­a­ses: a cross-sec­­ti­o­­nal mul­ti­cen­ter study among der­ma­to­lo­gi­cal out-pati­ents in 13 Euro­pean coun­tries. J Invest Der­ma­tol 2015; 135:984–991
  17. Berg­mann MM et al. Eva­lua­tion of food all­ergy in pati­ents with ato­pic der­ma­ti­tis. J All­ergy Clin Immu­nol Pract 2013; 1(1):22–28
  18. Wer­fel T et al. S2k-Lei­t­­li­­nie Neu­ro­der­mi­tis. J Dtsch Der­ma­tol Ges 2016; 14(1):92–106
  19. Pereira MP et al. Aktu­el­les zur Neu­ro­bio­lo­gie von Pru­ri­tus. Haut­arzt 2018; 69:620–625
  20. Raap U et al. IL-31 signi­fi­cantly cor­re­la­tes with dise­ase acti­vity and Th2 cyto­kine levels in child­ren with ato­pic der­ma­ti­tis. Ped All­ergy Immu­nol 2012; 23:285–288
  21. Wol­len­berg A, Bar­ba­rot S, Bie­ber T, Chris­­ten-Zaech S, Deleuran M, Fink-Wag­­ner A, Gie­ler U, Giro­lo­moni G, Lau S, Mur­aro A, Czar­ne­­cka-Ope­racz M, Schä­fer T, Schmid-Gren­­del­­meier P, Simon D, Sza­lai Z, Sze­pie­tow­ski JC, Taïeb A, Tor­relo A, Wer­fel T, Ring J; Euro­pean Der­ma­to­logy Forum (EDF), the Euro­pean Aca­demy of Der­ma­to­logy and Vene­reo­logy (EADV), the Euro­pean Aca­demy of All­ergy and Cli­ni­cal Immu­no­logy (EAACI), the Euro­pean Task Force on Ato­pic Der­ma­ti­tis (ETFAD), Euro­pean Fede­ra­tion of All­ergy and Air­ways Dise­a­ses Pati­ents’ Asso­cia­ti­ons (EFA), the Euro­pean­So­ciety for Der­ma­to­logy and Psych­ia­try (ESDaP), the Euro­pean Society of Pediatric Der­ma­to­logy (ESPD), Glo­bal All­ergy and Asthma Euro­pean Net­work (GA2LEN) and the Euro­pean Union of Medi­cal Spe­cia­lists (UEMS). Con­­sen­­sus-based Euro­pean gui­de­li­nes for tre­at­ment of ato­pic eczema (ato­pic der­ma­ti­tis) in adults and child­ren: part I. J Eur Acad Der­ma­tol Vene­reol. 2018 May;32(5):657–682
  22. Wol­len­berg A, Bar­ba­rot S, Bie­ber T, Chris­­ten-Zaech S, Deleuran M, Fink-Wag­­ner A, Gie­ler U, Giro­lo­moni G, Lau S, Mur­aro A, Czar­ne­­cka-Ope­racz M, Schä­fer T, Schmid-Gren­­del­­meier P, Simon D, Sza­lai Z, Sze­pie­tow­ski JC, Taïeb A, Tor­relo A, Wer­fel T, Ring J; Euro­pean Der­ma­to­logy Forum (EDF), the Euro­pean Aca­demy of Der­ma­to­logy and Vene­reo­logy (EADV), the Euro­pean Aca­demy of All­ergy and Cli­ni­cal Immu­no­logy (EAACI), the Euro­pean Task Force on Ato­pic Der­ma­ti­tis (ETFAD), Euro­pean Fede­ra­tion of All­ergy and Air­ways Dise­a­ses Pati­ents’ Asso­cia­ti­ons (EFA), the Euro­pean­So­ciety for Der­ma­to­logy and Psych­ia­try (ESDaP), the Euro­pean Society of Pediatric Der­ma­to­logy (ESPD), Glo­bal All­ergy and Asthma Euro­pean Net­work (GA2LEN) and the Euro­pean Union of Medi­cal Spe­cia­lists (UEMS). Con­­sen­­sus-based Euro­pean gui­de­li­nes for tre­at­ment of ato­pic eczema (ato­pic der­ma­ti­tis) in adults and child­ren: part II. J Eur Acad Der­ma­tol Vene­reol. 2018 Jun;32(6):850–878
  23. Staab D, Diep­gen TL, Far­tasch M, Kup­fer J, Lob-Cor­­zi­­lius T, Ring J, Scheewe S, Scheidt R, Schmid-Ott G, Schnopp C, Szc­ze­pan­ski R, Wer­fel T, Wit­ten­meier M, Wahn U, Gie­ler U. Age rela­ted, struc­tu­red edu­ca­tio­nal pro­gram­mes for the manage­ment of ato­pic der­ma­ti­tis in child­ren and ado­lescents: mul­ti­centre, ran­do­mi­sed con­trol­led trial. BMJ. 2006 Apr 22;332(7547):933–8
  24. Gru­ber et al, Eur J Hum Genet 2007, PMID 17164798

*) ao. Univ. Prof. Dr. Dr. Bea­trix Volc-Pla­t­­zer, em. Vor­stand der Der­ma­to­lo­gi­schen Abtei­lung im Donauspital/​SMZ Ost Wien; E‑Mail: beatrix.volc-platzer@meduniwien.ac.at

Lec­ture Board
Priv. Doz. Dr. Maxi­mi­lian Aichel­burg, Fach­arzt für Haut- und Geschlechts­krank­hei­ten, Wien
Priv. Doz. Dr. Robert Gru­ber, Uni­ver­si­täts­kli­nik für Der­ma­to­lo­gie und Venero­lo­gie, Medi­zi­ni­sche Uni­ver­si­tät Innsbruck

Ärzt­li­cher Fort­bil­dungs­an­bie­ter

Öster­rei­chi­sche Gesell­schaft für Der­ma­to­lo­gie und Venero­lo­gie (ÖGDV)

© Öster­rei­chi­sche Ärz­te­zei­tung Nr. 13–14 /​15.07.2019